MedPath

Cognitive Testing Online in Parkinson's Disease

Recruiting
Conditions
Parkinson Disease
Interventions
Other: Neurocognitive testing
Registration Number
NCT05025254
Lead Sponsor
McGill University
Brief Summary

This is a feasibility and pilot study. Though large-scale online neurocognitive testing is increasingly being done in psychiatry, there are no such efforts in Parkinson's research. Thus a large part of this pilot study will be to demonstrate feasibility and reliability, and use this experience to develop a feasible protocol for ongoing research. The specific short-term objectives are:

1. To establish the feasibility of performing large-scale deep cognitive phenotyping using online cognitive testing.

2. To demonstrate that online neurocognitive testing is valid and reliable in a smaller sample of locally recruited participants tested both in-lab and online.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • diagnosis of Parkinson's disease by neurologist or healthy individual with no diagnosis of any neurological illness
Exclusion Criteria
  • Psychotic spectrum disorders, active uncontrolled depression, advanced dementia (i.e. needing assistance with daily activities such as dressing or bathing), major stroke, major head injury, epilepsy requiring anti-seizure medications

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healthy controlsNeurocognitive testingThis is an observational study. The healthy control group will consist of participants who self-report that they do not have a diagnosis of Parkinson's disease
PD patientsNeurocognitive testingThis is an observational study. The PD patient group will consist of participants who self-report that they have a diagnosis of Parkinson's disease
Primary Outcome Measures
NameTimeMethod
Completion rate of cognitive test set (feasibility)Measured once, as this is a cross-sectional study (time to complete cognitive tests is estimated to be 1.5 hours)

Proportion of registered participants who complete all the cognitive testing.

Secondary Outcome Measures
NameTimeMethod
Reliability of web-based vs in-person executive function testing (Stroop test performance)Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart

Intraclass correlation coefficient for web-based vs. in-person performance on the Stroop test will be computed

Reliability of web-based vs in-person working memory testing (n-back test)Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart

Intraclass correlation coefficient for web-based vs. in-person performance on the n-back test will be computed

Reliability of web-based vs in-person reward processing testingWeb-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart

Intraclass correlation coefficient for web-based vs. in-person performance on the probabilistic reward task will be computed

Reliability of web-based vs in-person visuospatial function testing (Trail making test performance)Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart

Intraclass correlation coefficient for web-based vs. in-person performance on the Trail making test will be computed

Reliability of web-based vs in-person declarative memory testing (recognition memory)Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart

Intraclass correlation coefficient for web-based vs. in-person performance on the image recognition test will be computed

Trial Locations

Locations (1)

McGill University Health Centre

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath